Platelet Aggregation in the Diagnosis of Acute Graft Rejection
Recruiting
Observational Study
Platelet Aggregation
Kidney Transplant Rejection
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 60 (estimated)
- Sponsor
- University Hospital, Martin · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study titled "Platelet Aggregation in the Diagnosis of Acute Graft Rejection" is a pilot observational study evaluating whether alterations in platelet function can serve as non-invasive markers of acute rejection in kidney transplant recipients. Platelet aggregation is assessed using optical aggregometry, flow-cytometric P-selectin (CD62-P) expression, and soluble P-selectin levels before kid…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* adult patients (≥18 years)
* primary kidney transplantation
* living / deceased donor kidney transplantation
* ability and consent to participate
Exclusion Criteria:
* non-adult patients
* secondary / tertiary kidney transplantation
* antiplatelet therapy
* patients unable t…